Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
126M
-
Number of holders
-
13
-
Total 13F shares, excl. options
-
227K
-
Shares change
-
+8.14K
-
Total reported value, excl. options
-
$290K
-
Value change
-
+$136K
-
Number of buys
-
7
-
Number of sells
-
-7
-
Price
-
$1.28
Significant Holders of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) as of Q3 2025
18 filings reported holding NBY - NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value as of Q3 2025.
NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 227K shares
of 126M outstanding shares and own 0.18% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (84.5K shares), GEODE CAPITAL MANAGEMENT, LLC (51.7K shares), STATE STREET CORP (29.3K shares), Apollon Wealth Management, LLC (27.6K shares), Ground Swell Capital, LLC (19.2K shares), Virtu Financial LLC (11.1K shares), CITIGROUP INC (2.33K shares), Tower Research Capital LLC (TRC) (948 shares), BANK OF AMERICA CORP /DE/ (48 shares), and NVWM, LLC (3 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.